Literature DB >> 9580862

The mechanism of accumulation of tumour-localising radiopharmaceuticals.

E K Pauwels1, V R McCready, J H Stoot, D F van Deurzen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9580862     DOI： 10.1007/s002590050229

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  21 in total

1.  The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules.

Authors:  Richdeep S Gill; Troy Perry; Jonathan T Abele; Eric L R Bédard; Daniel Schiller
Journal:  World J Surg Oncol       Date:  2012-01-27       Impact factor: 2.754

Review 2.  Molecular imaging of pulmonary disease in vivo.

Authors:  Robin S Dothager; David Piwnica-Worms
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

3.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

4.  Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.

Authors:  E T Dams; M M Reijnen; W J Oyen; O C Boerman; P Laverman; G Storm; J W van der Meer; F H Corstens; H van Goor
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

5.  PET scans as a predictive marker of survival in advanced colorectal cancer.

Authors:  Minsig Choi; Sri Lakshmi S Kollepara; Lance K Heilbrun; Daryn Smith; Anthony F Shields; Philip A Philip
Journal:  Clin Colorectal Cancer       Date:  2014-10-23       Impact factor: 4.481

6.  In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.

Authors:  Teréz Márián; Gábor Szabó; Katalin Goda; Henrietta Nagy; Nóra Szincsák; István Juhász; László Galuska; László Balkay; Pál Mikecz; Lajos Trón; Zoltán Krasznai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-27       Impact factor: 9.236

7.  Role of PET/CT in the detection of liver metastases from colorectal cancer.

Authors:  A Orlacchio; O Schillaci; N Fusco; P Broccoli; M Maurici; M Yamgoue; R Danieli; S D'Urso; G Simonetti
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

8.  Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Kenji Kanenishi; Masami Ohno; Toshiyuki Hata; Yoshio Kushida; Reiji Haba; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-18       Impact factor: 9.236

9.  Early assessment of therapeutic response using FDG PET in small cell lung cancer.

Authors:  Y Yamamoto; R Kameyama; M Murota; S Bandoh; T Ishii; Y Nishiyama
Journal:  Mol Imaging Biol       Date:  2009-05-12       Impact factor: 3.488

10.  Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent.

Authors:  John E Cyr; Daniel A Pearson; Carol A Nelson; Barbara A Lyons; Yongyong Zheng; Judit Bartis; Jiafang He; Melchor V Cantorias; Robertha C Howell; Lynn C Francesconi
Journal:  J Med Chem       Date:  2007-08-11       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.